 | • レポートコード：MRC2-11QY00344 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、118ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は凝固因子濃縮物のグローバル市場について調査・分析したレポートです。種類別（第VIII因子、第IX因子、フォンウィルブランド因子、プロトロンビン複合体濃縮物、フィブリノーゲン濃縮物、第XIII因子）市場規模、用途別（神経学、免疫学、血液学、救命救急、呼吸器学、血液腫瘍学、リウマチ学、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別凝固因子濃縮物の競争状況、市場シェア ・世界の凝固因子濃縮物市場：種類別市場規模 2015年-2020年（第VIII因子、第IX因子、フォンウィルブランド因子、プロトロンビン複合体濃縮物、フィブリノーゲン濃縮物、第XIII因子） ・世界の凝固因子濃縮物市場：種類別市場規模予測 2021年-2026年（第VIII因子、第IX因子、フォンウィルブランド因子、プロトロンビン複合体濃縮物、フィブリノーゲン濃縮物、第XIII因子） ・世界の凝固因子濃縮物市場：用途別市場規模 2015年-2020年（神経学、免疫学、血液学、救命救急、呼吸器学、血液腫瘍学、リウマチ学、その他） ・世界の凝固因子濃縮物市場：用途別市場規模予測 2021年-2026年（神経学、免疫学、血液学、救命救急、呼吸器学、血液腫瘍学、リウマチ学、その他） ・北米の凝固因子濃縮物市場分析：米国、カナダ ・ヨーロッパの凝固因子濃縮物市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの凝固因子濃縮物市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の凝固因子濃縮物市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの凝固因子濃縮物市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：CSL (Australia)、Grifols (Spain)、Shire (Ireland)、Octapharma (Switzerland)、Kedrion (Italy)、Bio Product Laboratory (UK)、Sanquin (Netherlands)、LFB (France)、Biotest (Germany)、Japan Blood Products Organization, China Biologic Products (China)、Green Cross Corporation (South Korea)、Shanghai RAAS Blood Products (China) ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Coagulation Factor Concentrates Market
The global Coagulation Factor Concentrates market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Coagulation Factor Concentrates Scope and Market Size
Coagulation Factor Concentrates market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Coagulation Factor Concentrates market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Coagulation Factor Concentrates market is segmented into
Factor VIII
Factor IX
Von Willebrand Factor
Prothrombin Complex Concentrates
Fibrinogen Concentrates
Factor XIII
Segment by Application, the Coagulation Factor Concentrates market is segmented into
Neurology
Immunology
Hematology
Critical Care
Pulmonology
Hemato-Oncology
Rheumatology
Others
Regional and Country-level Analysis
The Coagulation Factor Concentrates market is analysed and market size information is provided by regions (countries).
The key regions covered in the Coagulation Factor Concentrates market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Coagulation Factor Concentrates Market Share Analysis
Coagulation Factor Concentrates market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Coagulation Factor Concentrates business, the date to enter into the Coagulation Factor Concentrates market, Coagulation Factor Concentrates product introduction, recent developments, etc.
The major vendors covered:
CSL (Australia)
Grifols (Spain)
Shire (Ireland)
Octapharma (Switzerland)
Kedrion (Italy)
Bio Product Laboratory (UK)
Sanquin (Netherlands)
LFB (France)
Biotest (Germany)
Japan Blood Products Organization, China Biologic Products (China)
Green Cross Corporation (South Korea)
Shanghai RAAS Blood Products (China)
1 Study Coverage
1.1 Coagulation Factor Concentrates Product Introduction
1.2 Market Segments
1.3 Key Coagulation Factor Concentrates Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Coagulation Factor Concentrates Market Size Growth Rate by Type
1.4.2 Factor VIII
1.4.3 Factor IX
1.4.4 Von Willebrand Factor
1.4.5 Prothrombin Complex Concentrates
1.4.6 Fibrinogen Concentrates
1.4.7 Factor XIII
1.5 Market by Application
1.5.1 Global Coagulation Factor Concentrates Market Size Growth Rate by Application
1.5.2 Neurology
1.5.3 Immunology
1.5.4 Hematology
1.5.5 Critical Care
1.5.6 Pulmonology
1.5.7 Hemato-Oncology
1.5.8 Rheumatology
1.5.9 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Coagulation Factor Concentrates Market Size, Estimates and Forecasts
2.1.1 Global Coagulation Factor Concentrates Revenue 2015-2026
2.1.2 Global Coagulation Factor Concentrates Sales 2015-2026
2.2 Global Coagulation Factor Concentrates, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Coagulation Factor Concentrates Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Coagulation Factor Concentrates Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Coagulation Factor Concentrates Competitor Landscape by Players
3.1 Coagulation Factor Concentrates Sales by Manufacturers
3.1.1 Coagulation Factor Concentrates Sales by Manufacturers (2015-2020)
3.1.2 Coagulation Factor Concentrates Sales Market Share by Manufacturers (2015-2020)
3.2 Coagulation Factor Concentrates Revenue by Manufacturers
3.2.1 Coagulation Factor Concentrates Revenue by Manufacturers (2015-2020)
3.2.2 Coagulation Factor Concentrates Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Coagulation Factor Concentrates Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Coagulation Factor Concentrates Revenue in 2019
3.2.5 Global Coagulation Factor Concentrates Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Coagulation Factor Concentrates Price by Manufacturers
3.4 Coagulation Factor Concentrates Manufacturing Base Distribution, Product Types
3.4.1 Coagulation Factor Concentrates Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Coagulation Factor Concentrates Product Type
3.4.3 Date of International Manufacturers Enter into Coagulation Factor Concentrates Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Coagulation Factor Concentrates Market Size by Type (2015-2020)
4.1.1 Global Coagulation Factor Concentrates Sales by Type (2015-2020)
4.1.2 Global Coagulation Factor Concentrates Revenue by Type (2015-2020)
4.1.3 Coagulation Factor Concentrates Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Coagulation Factor Concentrates Market Size Forecast by Type (2021-2026)
4.2.1 Global Coagulation Factor Concentrates Sales Forecast by Type (2021-2026)
4.2.2 Global Coagulation Factor Concentrates Revenue Forecast by Type (2021-2026)
4.2.3 Coagulation Factor Concentrates Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Coagulation Factor Concentrates Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Coagulation Factor Concentrates Market Size by Application (2015-2020)
5.1.1 Global Coagulation Factor Concentrates Sales by Application (2015-2020)
5.1.2 Global Coagulation Factor Concentrates Revenue by Application (2015-2020)
5.1.3 Coagulation Factor Concentrates Price by Application (2015-2020)
5.2 Coagulation Factor Concentrates Market Size Forecast by Application (2021-2026)
5.2.1 Global Coagulation Factor Concentrates Sales Forecast by Application (2021-2026)
5.2.2 Global Coagulation Factor Concentrates Revenue Forecast by Application (2021-2026)
5.2.3 Global Coagulation Factor Concentrates Price Forecast by Application (2021-2026)
6 North America
6.1 North America Coagulation Factor Concentrates by Country
6.1.1 North America Coagulation Factor Concentrates Sales by Country
6.1.2 North America Coagulation Factor Concentrates Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Coagulation Factor Concentrates Market Facts & Figures by Type
6.3 North America Coagulation Factor Concentrates Market Facts & Figures by Application
7 Europe
7.1 Europe Coagulation Factor Concentrates by Country
7.1.1 Europe Coagulation Factor Concentrates Sales by Country
7.1.2 Europe Coagulation Factor Concentrates Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Coagulation Factor Concentrates Market Facts & Figures by Type
7.3 Europe Coagulation Factor Concentrates Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Coagulation Factor Concentrates by Region
8.1.1 Asia Pacific Coagulation Factor Concentrates Sales by Region
8.1.2 Asia Pacific Coagulation Factor Concentrates Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Coagulation Factor Concentrates Market Facts & Figures by Type
8.3 Asia Pacific Coagulation Factor Concentrates Market Facts & Figures by Application
9 Latin America
9.1 Latin America Coagulation Factor Concentrates by Country
9.1.1 Latin America Coagulation Factor Concentrates Sales by Country
9.1.2 Latin America Coagulation Factor Concentrates Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Coagulation Factor Concentrates Market Facts & Figures by Type
9.3 Central & South America Coagulation Factor Concentrates Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Coagulation Factor Concentrates by Country
10.1.1 Middle East and Africa Coagulation Factor Concentrates Sales by Country
10.1.2 Middle East and Africa Coagulation Factor Concentrates Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Coagulation Factor Concentrates Market Facts & Figures by Type
10.3 Middle East and Africa Coagulation Factor Concentrates Market Facts & Figures by Application
11 Company Profiles
11.1 CSL (Australia)
11.1.1 CSL (Australia) Corporation Information
11.1.2 CSL (Australia) Description and Business Overview
11.1.3 CSL (Australia) Sales, Revenue and Gross Margin (2015-2020)
11.1.4 CSL (Australia) Coagulation Factor Concentrates Products Offered
11.1.5 CSL (Australia) Related Developments
11.2 Grifols (Spain)
11.2.1 Grifols (Spain) Corporation Information
11.2.2 Grifols (Spain) Description and Business Overview
11.2.3 Grifols (Spain) Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Grifols (Spain) Coagulation Factor Concentrates Products Offered
11.2.5 Grifols (Spain) Related Developments
11.3 Shire (Ireland)
11.3.1 Shire (Ireland) Corporation Information
11.3.2 Shire (Ireland) Description and Business Overview
11.3.3 Shire (Ireland) Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Shire (Ireland) Coagulation Factor Concentrates Products Offered
11.3.5 Shire (Ireland) Related Developments
11.4 Octapharma (Switzerland)
11.4.1 Octapharma (Switzerland) Corporation Information
11.4.2 Octapharma (Switzerland) Description and Business Overview
11.4.3 Octapharma (Switzerland) Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Octapharma (Switzerland) Coagulation Factor Concentrates Products Offered
11.4.5 Octapharma (Switzerland) Related Developments
11.5 Kedrion (Italy)
11.5.1 Kedrion (Italy) Corporation Information
11.5.2 Kedrion (Italy) Description and Business Overview
11.5.3 Kedrion (Italy) Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Kedrion (Italy) Coagulation Factor Concentrates Products Offered
11.5.5 Kedrion (Italy) Related Developments
11.6 Bio Product Laboratory (UK)
11.6.1 Bio Product Laboratory (UK) Corporation Information
11.6.2 Bio Product Laboratory (UK) Description and Business Overview
11.6.3 Bio Product Laboratory (UK) Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Bio Product Laboratory (UK) Coagulation Factor Concentrates Products Offered
11.6.5 Bio Product Laboratory (UK) Related Developments
11.7 Sanquin (Netherlands)
11.7.1 Sanquin (Netherlands) Corporation Information
11.7.2 Sanquin (Netherlands) Description and Business Overview
11.7.3 Sanquin (Netherlands) Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Sanquin (Netherlands) Coagulation Factor Concentrates Products Offered
11.7.5 Sanquin (Netherlands) Related Developments
11.8 LFB (France)
11.8.1 LFB (France) Corporation Information
11.8.2 LFB (France) Description and Business Overview
11.8.3 LFB (France) Sales, Revenue and Gross Margin (2015-2020)
11.8.4 LFB (France) Coagulation Factor Concentrates Products Offered
11.8.5 LFB (France) Related Developments
11.9 Biotest (Germany)
11.9.1 Biotest (Germany) Corporation Information
11.9.2 Biotest (Germany) Description and Business Overview
11.9.3 Biotest (Germany) Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Biotest (Germany) Coagulation Factor Concentrates Products Offered
11.9.5 Biotest (Germany) Related Developments
11.10 Japan Blood Products Organization, China Biologic Products (China)
11.10.1 Japan Blood Products Organization, China Biologic Products (China) Corporation Information
11.10.2 Japan Blood Products Organization, China Biologic Products (China) Description and Business Overview
11.10.3 Japan Blood Products Organization, China Biologic Products (China) Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Japan Blood Products Organization, China Biologic Products (China) Coagulation Factor Concentrates Products Offered
11.10.5 Japan Blood Products Organization, China Biologic Products (China) Related Developments
11.1 CSL (Australia)
11.1.1 CSL (Australia) Corporation Information
11.1.2 CSL (Australia) Description and Business Overview
11.1.3 CSL (Australia) Sales, Revenue and Gross Margin (2015-2020)
11.1.4 CSL (Australia) Coagulation Factor Concentrates Products Offered
11.1.5 CSL (Australia) Related Developments
11.12 Shanghai RAAS Blood Products (China)
11.12.1 Shanghai RAAS Blood Products (China) Corporation Information
11.12.2 Shanghai RAAS Blood Products (China) Description and Business Overview
11.12.3 Shanghai RAAS Blood Products (China) Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Shanghai RAAS Blood Products (China) Products Offered
11.12.5 Shanghai RAAS Blood Products (China) Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Coagulation Factor Concentrates Market Estimates and Projections by Region
12.1.1 Global Coagulation Factor Concentrates Sales Forecast by Regions 2021-2026
12.1.2 Global Coagulation Factor Concentrates Revenue Forecast by Regions 2021-2026
12.2 North America Coagulation Factor Concentrates Market Size Forecast (2021-2026)
12.2.1 North America: Coagulation Factor Concentrates Sales Forecast (2021-2026)
12.2.2 North America: Coagulation Factor Concentrates Revenue Forecast (2021-2026)
12.2.3 North America: Coagulation Factor Concentrates Market Size Forecast by Country (2021-2026)
12.3 Europe Coagulation Factor Concentrates Market Size Forecast (2021-2026)
12.3.1 Europe: Coagulation Factor Concentrates Sales Forecast (2021-2026)
12.3.2 Europe: Coagulation Factor Concentrates Revenue Forecast (2021-2026)
12.3.3 Europe: Coagulation Factor Concentrates Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Coagulation Factor Concentrates Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Coagulation Factor Concentrates Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Coagulation Factor Concentrates Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Coagulation Factor Concentrates Market Size Forecast by Region (2021-2026)
12.5 Latin America Coagulation Factor Concentrates Market Size Forecast (2021-2026)
12.5.1 Latin America: Coagulation Factor Concentrates Sales Forecast (2021-2026)
12.5.2 Latin America: Coagulation Factor Concentrates Revenue Forecast (2021-2026)
12.5.3 Latin America: Coagulation Factor Concentrates Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Coagulation Factor Concentrates Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Coagulation Factor Concentrates Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Coagulation Factor Concentrates Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Coagulation Factor Concentrates Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Coagulation Factor Concentrates Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Coagulation Factor Concentrates Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Coagulation Factor Concentrates Market Segments
Table 2. Ranking of Global Top Coagulation Factor Concentrates Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Coagulation Factor Concentrates Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Factor VIII
Table 5. Major Manufacturers of Factor IX
Table 6. Major Manufacturers of Von Willebrand Factor
Table 7. Major Manufacturers of Prothrombin Complex Concentrates
Table 8. Major Manufacturers of Fibrinogen Concentrates
Table 9. Major Manufacturers of Factor XIII
Table 10. Global Coagulation Factor Concentrates Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 11. Global Coagulation Factor Concentrates Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 12. Global Coagulation Factor Concentrates Sales by Regions 2015-2020 (K Pcs)
Table 13. Global Coagulation Factor Concentrates Sales Market Share by Regions (2015-2020)
Table 14. Global Coagulation Factor Concentrates Revenue by Regions 2015-2020 (US$ Million)
Table 15. Global Coagulation Factor Concentrates Sales by Manufacturers (2015-2020) (K Pcs)
Table 16. Global Coagulation Factor Concentrates Sales Share by Manufacturers (2015-2020)
Table 17. Global Coagulation Factor Concentrates Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 18. Global Coagulation Factor Concentrates by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Coagulation Factor Concentrates as of 2019)
Table 19. Coagulation Factor Concentrates Revenue by Manufacturers (2015-2020) (US$ Million)
Table 20. Coagulation Factor Concentrates Revenue Share by Manufacturers (2015-2020)
Table 21. Key Manufacturers Coagulation Factor Concentrates Price (2015-2020) (USD/Pcs)
Table 22. Coagulation Factor Concentrates Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Coagulation Factor Concentrates Product Type
Table 24. Date of International Manufacturers Enter into Coagulation Factor Concentrates Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Coagulation Factor Concentrates Sales by Type (2015-2020) (K Pcs)
Table 27. Global Coagulation Factor Concentrates Sales Share by Type (2015-2020)
Table 28. Global Coagulation Factor Concentrates Revenue by Type (2015-2020) (US$ Million)
Table 29. Global Coagulation Factor Concentrates Revenue Share by Type (2015-2020)
Table 30. Coagulation Factor Concentrates Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 31. Global Coagulation Factor Concentrates Sales by Application (2015-2020) (K Pcs)
Table 32. Global Coagulation Factor Concentrates Sales Share by Application (2015-2020)
Table 33. North America Coagulation Factor Concentrates Sales by Country (2015-2020) (K Pcs)
Table 34. North America Coagulation Factor Concentrates Sales Market Share by Country (2015-2020)
Table 35. North America Coagulation Factor Concentrates Revenue by Country (2015-2020) (US$ Million)
Table 36. North America Coagulation Factor Concentrates Revenue Market Share by Country (2015-2020)
Table 37. North America Coagulation Factor Concentrates Sales by Type (2015-2020) (K Pcs)
Table 38. North America Coagulation Factor Concentrates Sales Market Share by Type (2015-2020)
Table 39. North America Coagulation Factor Concentrates Sales by Application (2015-2020) (K Pcs)
Table 40. North America Coagulation Factor Concentrates Sales Market Share by Application (2015-2020)
Table 41. Europe Coagulation Factor Concentrates Sales by Country (2015-2020) (K Pcs)
Table 42. Europe Coagulation Factor Concentrates Sales Market Share by Country (2015-2020)
Table 43. Europe Coagulation Factor Concentrates Revenue by Country (2015-2020) (US$ Million)
Table 44. Europe Coagulation Factor Concentrates Revenue Market Share by Country (2015-2020)
Table 45. Europe Coagulation Factor Concentrates Sales by Type (2015-2020) (K Pcs)
Table 46. Europe Coagulation Factor Concentrates Sales Market Share by Type (2015-2020)
Table 47. Europe Coagulation Factor Concentrates Sales by Application (2015-2020) (K Pcs)
Table 48. Europe Coagulation Factor Concentrates Sales Market Share by Application (2015-2020)
Table 49. Asia Pacific Coagulation Factor Concentrates Sales by Region (2015-2020) (K Pcs)
Table 50. Asia Pacific Coagulation Factor Concentrates Sales Market Share by Region (2015-2020)
Table 51. Asia Pacific Coagulation Factor Concentrates Revenue by Region (2015-2020) (US$ Million)
Table 52. Asia Pacific Coagulation Factor Concentrates Revenue Market Share by Region (2015-2020)
Table 53. Asia Pacific Coagulation Factor Concentrates Sales by Type (2015-2020) (K Pcs)
Table 54. Asia Pacific Coagulation Factor Concentrates Sales Market Share by Type (2015-2020)
Table 55. Asia Pacific Coagulation Factor Concentrates Sales by Application (2015-2020) (K Pcs)
Table 56. Asia Pacific Coagulation Factor Concentrates Sales Market Share by Application (2015-2020)
Table 57. Latin America Coagulation Factor Concentrates Sales by Country (2015-2020) (K Pcs)
Table 58. Latin America Coagulation Factor Concentrates Sales Market Share by Country (2015-2020)
Table 59. Latin Americaa Coagulation Factor Concentrates Revenue by Country (2015-2020) (US$ Million)
Table 60. Latin America Coagulation Factor Concentrates Revenue Market Share by Country (2015-2020)
Table 61. Latin America Coagulation Factor Concentrates Sales by Type (2015-2020) (K Pcs)
Table 62. Latin America Coagulation Factor Concentrates Sales Market Share by Type (2015-2020)
Table 63. Latin America Coagulation Factor Concentrates Sales by Application (2015-2020) (K Pcs)
Table 64. Latin America Coagulation Factor Concentrates Sales Market Share by Application (2015-2020)
Table 65. Middle East and Africa Coagulation Factor Concentrates Sales by Country (2015-2020) (K Pcs)
Table 66. Middle East and Africa Coagulation Factor Concentrates Sales Market Share by Country (2015-2020)
Table 67. Middle East and Africa Coagulation Factor Concentrates Revenue by Country (2015-2020) (US$ Million)
Table 68. Middle East and Africa Coagulation Factor Concentrates Revenue Market Share by Country (2015-2020)
Table 69. Middle East and Africa Coagulation Factor Concentrates Sales by Type (2015-2020) (K Pcs)
Table 70. Middle East and Africa Coagulation Factor Concentrates Sales Market Share by Type (2015-2020)
Table 71. Middle East and Africa Coagulation Factor Concentrates Sales by Application (2015-2020) (K Pcs)
Table 72. Middle East and Africa Coagulation Factor Concentrates Sales Market Share by Application (2015-2020)
Table 73. CSL (Australia) Corporation Information
Table 74. CSL (Australia) Description and Major Businesses
Table 75. CSL (Australia) Coagulation Factor Concentrates Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 76. CSL (Australia) Product
Table 77. CSL (Australia) Recent Development
Table 78. Grifols (Spain) Corporation Information
Table 79. Grifols (Spain) Description and Major Businesses
Table 80. Grifols (Spain) Coagulation Factor Concentrates Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 81. Grifols (Spain) Product
Table 82. Grifols (Spain) Recent Development
Table 83. Shire (Ireland) Corporation Information
Table 84. Shire (Ireland) Description and Major Businesses
Table 85. Shire (Ireland) Coagulation Factor Concentrates Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 86. Shire (Ireland) Product
Table 87. Shire (Ireland) Recent Development
Table 88. Octapharma (Switzerland) Corporation Information
Table 89. Octapharma (Switzerland) Description and Major Businesses
Table 90. Octapharma (Switzerland) Coagulation Factor Concentrates Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 91. Octapharma (Switzerland) Product
Table 92. Octapharma (Switzerland) Recent Development
Table 93. Kedrion (Italy) Corporation Information
Table 94. Kedrion (Italy) Description and Major Businesses
Table 95. Kedrion (Italy) Coagulation Factor Concentrates Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 96. Kedrion (Italy) Product
Table 97. Kedrion (Italy) Recent Development
Table 98. Bio Product Laboratory (UK) Corporation Information
Table 99. Bio Product Laboratory (UK) Description and Major Businesses
Table 100. Bio Product Laboratory (UK) Coagulation Factor Concentrates Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 101. Bio Product Laboratory (UK) Product
Table 102. Bio Product Laboratory (UK) Recent Development
Table 103. Sanquin (Netherlands) Corporation Information
Table 104. Sanquin (Netherlands) Description and Major Businesses
Table 105. Sanquin (Netherlands) Coagulation Factor Concentrates Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 106. Sanquin (Netherlands) Product
Table 107. Sanquin (Netherlands) Recent Development
Table 108. LFB (France) Corporation Information
Table 109. LFB (France) Description and Major Businesses
Table 110. LFB (France) Coagulation Factor Concentrates Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 111. LFB (France) Product
Table 112. LFB (France) Recent Development
Table 113. Biotest (Germany) Corporation Information
Table 114. Biotest (Germany) Description and Major Businesses
Table 115. Biotest (Germany) Coagulation Factor Concentrates Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 116. Biotest (Germany) Product
Table 117. Biotest (Germany) Recent Development
Table 118. Japan Blood Products Organization, China Biologic Products (China) Corporation Information
Table 119. Japan Blood Products Organization, China Biologic Products (China) Description and Major Businesses
Table 120. Japan Blood Products Organization, China Biologic Products (China) Coagulation Factor Concentrates Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 121. Japan Blood Products Organization, China Biologic Products (China) Product
Table 122. Japan Blood Products Organization, China Biologic Products (China) Recent Development
Table 123. Green Cross Corporation (South Korea) Corporation Information
Table 124. Green Cross Corporation (South Korea) Description and Major Businesses
Table 125. Green Cross Corporation (South Korea) Coagulation Factor Concentrates Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 126. Green Cross Corporation (South Korea) Product
Table 127. Green Cross Corporation (South Korea) Recent Development
Table 128. Shanghai RAAS Blood Products (China) Corporation Information
Table 129. Shanghai RAAS Blood Products (China) Description and Major Businesses
Table 130. Shanghai RAAS Blood Products (China) Coagulation Factor Concentrates Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 131. Shanghai RAAS Blood Products (China) Product
Table 132. Shanghai RAAS Blood Products (China) Recent Development
Table 133. Global Coagulation Factor Concentrates Sales Forecast by Regions (2021-2026) (K Pcs)
Table 134. Global Coagulation Factor Concentrates Sales Market Share Forecast by Regions (2021-2026)
Table 135. Global Coagulation Factor Concentrates Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 136. Global Coagulation Factor Concentrates Revenue Market Share Forecast by Regions (2021-2026)
Table 137. North America: Coagulation Factor Concentrates Sales Forecast by Country (2021-2026) (K Pcs)
Table 138. North America: Coagulation Factor Concentrates Revenue Forecast by Country (2021-2026) (US$ Million)
Table 139. Europe: Coagulation Factor Concentrates Sales Forecast by Country (2021-2026) (K Pcs)
Table 140. Europe: Coagulation Factor Concentrates Revenue Forecast by Country (2021-2026) (US$ Million)
Table 141. Asia Pacific: Coagulation Factor Concentrates Sales Forecast by Region (2021-2026) (K Pcs)
Table 142. Asia Pacific: Coagulation Factor Concentrates Revenue Forecast by Region (2021-2026) (US$ Million)
Table 143. Latin America: Coagulation Factor Concentrates Sales Forecast by Country (2021-2026) (K Pcs)
Table 144. Latin America: Coagulation Factor Concentrates Revenue Forecast by Country (2021-2026) (US$ Million)
Table 145. Middle East and Africa: Coagulation Factor Concentrates Sales Forecast by Country (2021-2026) (K Pcs)
Table 146. Middle East and Africa: Coagulation Factor Concentrates Revenue Forecast by Country (2021-2026) (US$ Million)
Table 147. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 148. Key Challenges
Table 149. Market Risks
Table 150. Main Points Interviewed from Key Coagulation Factor Concentrates Players
Table 151. Coagulation Factor Concentrates Customers List
Table 152. Coagulation Factor Concentrates Distributors List
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Coagulation Factor Concentrates Product Picture
Figure 2. Global Coagulation Factor Concentrates Sales Market Share by Type in 2020 & 2026
Figure 3. Factor VIII Product Picture
Figure 4. Factor IX Product Picture
Figure 5. Von Willebrand Factor Product Picture
Figure 6. Prothrombin Complex Concentrates Product Picture
Figure 7. Fibrinogen Concentrates Product Picture
Figure 8. Factor XIII Product Picture
Figure 9. Global Coagulation Factor Concentrates Sales Market Share by Application in 2020 & 2026
Figure 10. Neurology
Figure 11. Immunology
Figure 12. Hematology
Figure 13. Critical Care
Figure 14. Pulmonology
Figure 15. Hemato-Oncology
Figure 16. Rheumatology
Figure 17. Others
Figure 18. Coagulation Factor Concentrates Report Years Considered
Figure 19. Global Coagulation Factor Concentrates Market Size 2015-2026 (US$ Million)
Figure 20. Global Coagulation Factor Concentrates Sales 2015-2026 (K Pcs)
Figure 21. Global Coagulation Factor Concentrates Market Size Market Share by Region: 2020 Versus 2026
Figure 22. Global Coagulation Factor Concentrates Sales Market Share by Region (2015-2020)
Figure 23. Global Coagulation Factor Concentrates Sales Market Share by Region in 2019
Figure 24. Global Coagulation Factor Concentrates Revenue Market Share by Region (2015-2020)
Figure 25. Global Coagulation Factor Concentrates Revenue Market Share by Region in 2019
Figure 26. Global Coagulation Factor Concentrates Sales Share by Manufacturer in 2019
Figure 27. The Top 10 and 5 Players Market Share by Coagulation Factor Concentrates Revenue in 2019
Figure 28. Coagulation Factor Concentrates Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global Coagulation Factor Concentrates Sales Market Share by Type (2015-2020)
Figure 30. Global Coagulation Factor Concentrates Sales Market Share by Type in 2019
Figure 31. Global Coagulation Factor Concentrates Revenue Market Share by Type (2015-2020)
Figure 32. Global Coagulation Factor Concentrates Revenue Market Share by Type in 2019
Figure 33. Global Coagulation Factor Concentrates Market Share by Price Range (2015-2020)
Figure 34. Global Coagulation Factor Concentrates Sales Market Share by Application (2015-2020)
Figure 35. Global Coagulation Factor Concentrates Sales Market Share by Application in 2019
Figure 36. Global Coagulation Factor Concentrates Revenue Market Share by Application (2015-2020)
Figure 37. Global Coagulation Factor Concentrates Revenue Market Share by Application in 2019
Figure 38. North America Coagulation Factor Concentrates Sales Growth Rate 2015-2020 (K Pcs)
Figure 39. North America Coagulation Factor Concentrates Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. North America Coagulation Factor Concentrates Sales Market Share by Country in 2019
Figure 41. North America Coagulation Factor Concentrates Revenue Market Share by Country in 2019
Figure 42. U.S. Coagulation Factor Concentrates Sales Growth Rate (2015-2020) (K Pcs)
Figure 43. U.S. Coagulation Factor Concentrates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. Canada Coagulation Factor Concentrates Sales Growth Rate (2015-2020) (K Pcs)
Figure 45. Canada Coagulation Factor Concentrates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. North America Coagulation Factor Concentrates Market Share by Type in 2019
Figure 47. North America Coagulation Factor Concentrates Market Share by Application in 2019
Figure 48. Europe Coagulation Factor Concentrates Sales Growth Rate 2015-2020 (K Pcs)
Figure 49. Europe Coagulation Factor Concentrates Revenue Growth Rate 2015-2020 (US$ Million)
Figure 50. Europe Coagulation Factor Concentrates Sales Market Share by Country in 2019
Figure 51. Europe Coagulation Factor Concentrates Revenue Market Share by Country in 2019
Figure 52. Germany Coagulation Factor Concentrates Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. Germany Coagulation Factor Concentrates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. France Coagulation Factor Concentrates Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. France Coagulation Factor Concentrates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. U.K. Coagulation Factor Concentrates Sales Growth Rate (2015-2020) (K Pcs)
Figure 57. U.K. Coagulation Factor Concentrates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Italy Coagulation Factor Concentrates Sales Growth Rate (2015-2020) (K Pcs)
Figure 59. Italy Coagulation Factor Concentrates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Russia Coagulation Factor Concentrates Sales Growth Rate (2015-2020) (K Pcs)
Figure 61. Russia Coagulation Factor Concentrates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Europe Coagulation Factor Concentrates Market Share by Type in 2019
Figure 63. Europe Coagulation Factor Concentrates Market Share by Application in 2019
Figure 64. Asia Pacific Coagulation Factor Concentrates Sales Growth Rate 2015-2020 (K Pcs)
Figure 65. Asia Pacific Coagulation Factor Concentrates Revenue Growth Rate 2015-2020 (US$ Million)
Figure 66. Asia Pacific Coagulation Factor Concentrates Sales Market Share by Region in 2019
Figure 67. Asia Pacific Coagulation Factor Concentrates Revenue Market Share by Region in 2019
Figure 68. China Coagulation Factor Concentrates Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. China Coagulation Factor Concentrates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Japan Coagulation Factor Concentrates Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Japan Coagulation Factor Concentrates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. South Korea Coagulation Factor Concentrates Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. South Korea Coagulation Factor Concentrates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. India Coagulation Factor Concentrates Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. India Coagulation Factor Concentrates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Australia Coagulation Factor Concentrates Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Australia Coagulation Factor Concentrates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Taiwan Coagulation Factor Concentrates Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Taiwan Coagulation Factor Concentrates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Indonesia Coagulation Factor Concentrates Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Indonesia Coagulation Factor Concentrates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Thailand Coagulation Factor Concentrates Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Thailand Coagulation Factor Concentrates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Malaysia Coagulation Factor Concentrates Sales Growth Rate (2015-2020) (K Pcs)
Figure 85. Malaysia Coagulation Factor Concentrates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Philippines Coagulation Factor Concentrates Sales Growth Rate (2015-2020) (K Pcs)
Figure 87. Philippines Coagulation Factor Concentrates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Vietnam Coagulation Factor Concentrates Sales Growth Rate (2015-2020) (K Pcs)
Figure 89. Vietnam Coagulation Factor Concentrates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Asia Pacific Coagulation Factor Concentrates Market Share by Type in 2019
Figure 91. Asia Pacific Coagulation Factor Concentrates Market Share by Application in 2019
Figure 92. Latin America Coagulation Factor Concentrates Sales Growth Rate 2015-2020 (K Pcs)
Figure 93. Latin America Coagulation Factor Concentrates Revenue Growth Rate 2015-2020 (US$ Million)
Figure 94. Latin America Coagulation Factor Concentrates Sales Market Share by Country in 2019
Figure 95. Latin America Coagulation Factor Concentrates Revenue Market Share by Country in 2019
Figure 96. Mexico Coagulation Factor Concentrates Sales Growth Rate (2015-2020) (K Pcs)
Figure 97. Mexico Coagulation Factor Concentrates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Brazil Coagulation Factor Concentrates Sales Growth Rate (2015-2020) (K Pcs)
Figure 99. Brazil Coagulation Factor Concentrates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Argentina Coagulation Factor Concentrates Sales Growth Rate (2015-2020) (K Pcs)
Figure 101. Argentina Coagulation Factor Concentrates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Latin America Coagulation Factor Concentrates Market Share by Type in 2019
Figure 103. Latin America Coagulation Factor Concentrates Market Share by Application in 2019
Figure 104. Middle East and Africa Coagulation Factor Concentrates Sales Growth Rate 2015-2020 (K Pcs)
Figure 105. Middle East and Africa Coagulation Factor Concentrates Revenue Growth Rate 2015-2020 (US$ Million)
Figure 106. Middle East and Africa Coagulation Factor Concentrates Sales Market Share by Country in 2019
Figure 107. Middle East and Africa Coagulation Factor Concentrates Revenue Market Share by Country in 2019
Figure 108. Turkey Coagulation Factor Concentrates Sales Growth Rate (2015-2020) (K Pcs)
Figure 109. Turkey Coagulation Factor Concentrates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. Saudi Arabia Coagulation Factor Concentrates Sales Growth Rate (2015-2020) (K Pcs)
Figure 111. Saudi Arabia Coagulation Factor Concentrates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 112. U.A.E Coagulation Factor Concentrates Sales Growth Rate (2015-2020) (K Pcs)
Figure 113. U.A.E Coagulation Factor Concentrates Revenue Growth Rate (2015-2020) (US$ Million)
Figure 114. Middle East and Africa Coagulation Factor Concentrates Market Share by Type in 2019
Figure 115. Middle East and Africa Coagulation Factor Concentrates Market Share by Application in 2019
Figure 116. North America Coagulation Factor Concentrates Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. North America Coagulation Factor Concentrates Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Europe Coagulation Factor Concentrates Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Europe Coagulation Factor Concentrates Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Asia Pacific Coagulation Factor Concentrates Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 121. Asia Pacific Coagulation Factor Concentrates Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Latin America Coagulation Factor Concentrates Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 123. Latin America Coagulation Factor Concentrates Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 124. Middle East and Africa Coagulation Factor Concentrates Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 125. Middle East and Africa Coagulation Factor Concentrates Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 126. Porter's Five Forces Analysis
Figure 127. Channels of Distribution
Figure 128. Distributors Profiles
Figure 129. Bottom-up and Top-down Approaches for This Report
Figure 130. Data Triangulation
Figure 131. Key Executives Interviewed
凝固XI因子の世界市場（～2026年） Market Analysis and Insights: Global Coagulation Factor XI Market The global Coagulation Factor XI market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Coagulation Factor XI Scope and Market Size Coagulation Factor XI marke…- ヒト凝固因子IXの世界市場（～2026年） Market Analysis and Insights: Global Human Coagulation Factor IX Market The global Human Coagulation Factor IX market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Human Coagulation Factor IX Scope and Market Size Human Coa…
- ヒト凝固因子IVの世界市場（～2026年） Market Analysis and Insights: Global Human Coagulation Factor IV Market The global Human Coagulation Factor IV market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Human Coagulation Factor IV Scope and Market Size Human Coa…
- 第VIII因子欠乏症治療の世界市場（～2026年） Factor VIII is an essential blood-clotting protein, which is also known as an antihemophilic factor. In individuals, factor VIII is encoded by F8 gene. Defects in F8 gene lead to hemophilia A, a recessive X-linked coagulation disorder. Factor VIII is generated in liver sinusoidal cells and endotheli…
- 第IX因子欠乏症治療の世界市場（～2026年） Factor IX (or Christmas factor) is one of the serine proteases of the coagulation system; it belongs to peptidase family S1. Deficiency of this protein causes hemophilia B. In this market study, analysts have estimated the prophylaxis segment to dominate the factor IX deficiency treatment market dur…